Protein carbonylation in human diseases

Trends in Molecular Medicine

Volumn 9, Issue 4, 2003, Pages 169-176

  Dalle Donne, Isabella ^a   Giustarini, Daniela ^b   Colombo, Roberto ^a   Rossi, Ranieri ^b   Milzani, Aldo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BETA CAROTENE; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; DEFEROXAMINE; ENZYME; ESTROGEN; GAMMA TOCOPHEROL; GINKGO BILOBA EXTRACT; SELEGILINE; STRUCTURAL PROTEIN;

ALZHEIMER DISEASE; CHRONIC KIDNEY FAILURE; CHRONIC LUNG DISEASE; DIABETES MELLITUS; HUMAN; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN CARBONYLATION; PROTEIN DEFECT; PROTEIN MODIFICATION; REVIEW; SEPSIS;

GINKGO BILOBA;

EID: 0038475847     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(03)00031-5     Document Type: Review

References (67)

1. Halliwell, B. and Gutteridge, J. (1999) Free Radicals in Biology and Medicine, 3rd edn, Oxford University Press
2. Hensley, K. et al. (2000) Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med. 28, 1456-1462
3. Berlett, B.S. and Stadtman, E.R. (1997) Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272, 20313-20316
4. Pantke, U. et al. (1999) Oxidized proteins as a marker of oxidative stress during coronary heart surgery. Free Radic. Biol. Med. 27, 1080-1086
5. Shacter, E. (2000) Quantification and significance of protein oxidation in biological samples. Drug Metab. Rev. 32, 307-326
6. Beal, M.F. (2002) Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med. 32, 797-803
7. Conrad, C.C. et al. (2001) Identification of protein carbonyls after two-dimensional electrophoresis. Proteomics 1, 829-834
8. Castegna, A. et al. (2002) Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic. Biol. Med. 33, 562-571
9. Davies, M.J. et al. (1999) Stable markers of oxidant damage to proteins and their application in study of human disease. Free Radic. Biol. Med. 27, 1151-1161
10. Butterfield, D.A. et al. (2001) Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide. Trends Mol. Med. 7, 548-554
11. Butterfield, D.A. et al. (2002) Evidence that amyloid β-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol. Aging 23, 655-664
12. Butterfield, D.A. and Lauderback, C.M. (2002) Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress. Free Radic. Biol. Med. 32, 1050-1060
13. Hensley, K. et al. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156
14. Aksenov, M.Y. et al. (2001) Protein oxidation in the brain in Alzheimer's disease. Neuroscience 103, 373-383
15. Smith, M.A. et al. (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121
16. Perry, G. et al. (2000) How important is oxidative damage? Lessons from Alzheimer's disease. Free Radic. Biol. Med. 28, 831-843
17. Stolzing, A. and Grune, T. (2001) The proteasome and its function in the ageing process. Clin. Exp. Dermatol. 26, 566-572
18. Job, C. and Eberwine, J. (2001) Localization and translation of mRNA in dendrites and axons. Nat. Rev. Neurosci. 2, 889-898
19. Jiang, C. and Schuman, E.M. (2002) Regulation and function of local protein synthesis in neuronal dendrites. Trends Biochem. Sci. 27, 506-513
20. Piwien-Pilipuk, G. et al. (2002) Impairment of mineralocorticoid receptor (MR)-dependent biological response by oxidative stress and aging: correlation with post-translational modification of MR and decreased ADP-ribosylatable level of elongating factor 2 in kidney cells. J. Biol. Chem. 277, 11896-11903
21. Aksenov, M.Y. et al. (2000) Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J. Neurochem. 74, 2520-2527
22. Castegna, A. et al. (2002) Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain Part II: dihydropyrimidinase-related protein 2, α-enolase and heat shock cognate 71. J. Neurochem. 82, 1524-1532
23. Parinandi, N.L. et al. (2003) Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L26-L38
24. Gladstone, I.M. Jr. and Levine, R.L. (1994) Oxidation of proteins in neonatal lungs. Pediatrics 93, 764-768
25. Schock, B.C. et al. (2001) Oxidative stress in lavage fluid of preterm infants at risk of chronic lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L1386-L1391
26. Buss, H. et al. (2000) Elevated protein carbonyls and lipid peroxidation products correlating with myeloperoxidase in tracheal aspirates from premature infants. Pediatr. Res. 47, 640-645
27. Ramsay, P.L. et al. (2001) Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 164, 155-161
28. Himmelfarb, J. et al. (2000) Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int. 58, 2571-2578
29. Himmelfarb, J. and McMonagle, E. (2001) Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int. 60, 358-363
30. Agarwal, R. Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade. Am. J. Physiol. Renal Physiol. (in press)
31. Lim, P.S. et al. (2002) Increase in oxidative damage to lipids and proteins in skeletal muscle of uremic patients. Free Radic. Res. 36, 295-301
32. Miyata, T. et al. (2000) 'Carbonyl stress' and dialysis-related amyloidosis. Nephrol. Dial. Transplant. 15, 25-28
33. Miyata, T. et al. (1999) Alterations in nonenzymatic biochemistry in uremia: origin and significance of carbonyl stress in long-term uremic complications. Kidney Int. 55, 389-399
34. Singh, R. et al. (2001) Advanced glycation end-products: a review. Diabetologia 44, 129-146
35. Dominguez, C. et al. (1998) Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 21, 1736-1742
36. Cakatay, U. et al. (2000) Oxidative protein damage in type I diabetic patients with and without complications. Endocr. Res. 26, 365-379
37. Telci, A. et al. (2000) Oxidative protein damage in early stage type 1 diabetic patients. Diabetes Res. Clin. Pract. 50, 213-223
38. Telci, A. et al. (2000) Oxidative protein damage in plasma of type 2 diabetic patients. Horm. Metab. Res. 32, 40-43
39. Grattagliano, I. et al. (1998) Oxidative retinal products and ocular damages in diabetic patients. Free Radic. Biol. Med. 25, 369-372
40. Winterbourn, C.C. et al. (2000) Protein carbonyl measurements show evidence of early oxidative stress in critically ill patients. Crit. Care Med. 28, 143-149
41. Abu-Zidan, F.M. et al. (2002) Proteolysis in severe sepsis is related to oxidation of plasma protein. Eur. J. Surg. 168, 119-123
42. Conrad, C.C. et al. (2000) Oxidized proteins in Alzheimer's plasma. Biochem. Biophys. Res. Commun. 275, 678-681
43. Dukan, S. et al. (2000) Protein oxidation in response to increased transcriptional or translational errors. Proc. Natl. Acad. Sci. U. S. A. 97, 5746-5749
44. Ballesteros, M. et al. (2001) Bacterial senescence: protein oxidation in non-proliferating cells is dictated by the accuracy of the ribosomes. EMBO J. 20, 5280-5289
45. Choi, J. et al. (2002) Identification of oxidized plasma proteins in Alzheimer's disease. Biochem. Biophys. Res. Commun. 293, 1566-1570
46. Dalle-Donne, I. et al. (2001) Actin carbonylation: from a simple marker of protein oxidation to relevant signs of severe functional impairment. Free Radic. Biol. Med. 31, 1075-1083
47. Dalle-Donne, I. et al. (2002) Methionine oxidation as a major cause of the functional impairment of oxidized actin. Free Radic. Biol. Med. 32, 927-937
48. Powell, S.R. et al. (2001) Actin is oxidized during myocardial ischemia. Free Radic. Biol. Med. 30, 1171-1176
49. Banan, A. et al. (2000) Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor α in a human colonic cell line. Gut 46, 830-837
50. Gabbita, S.P. et al. (1999) Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J. Neurochem. 73, 1660-1666
51. Christen, Y. (2000) Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 71, 621S-629S
52. Picklo, M.J. et al. (2002) Carbonyl toxicology and Alzheimer's disease. Toxicol. Appl. Pharmacol. 184, 187-197
53. Beal, M.F. et al. (1997) Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42, 644-654
54. Ferrante, R.J. et al. (1997) Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69, 2064-2074
55. Pedersen, W.A. et al. (1998) Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol. 44, 819-824
56. Requena, J.R. et al. (2001) Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc. Natl. Acad. Sci. U. S. A. 98, 69-78
57. Lenz, A.G. et al. (1999) Oxidatively modified proteins in bronchoalveolar lavage fluid of patients with ARDS and patients at-risk for ARDS. Eur. Respir. J. 13, 169-174
58. Boscia, F. et al. (2000) Protein oxidation and lens opacity in humans. Invest. Ophthalmol. Vis. Sci. 41, 2461-2465
59. McGrath, L.T. et al. (1999) Oxidative stress during acute respiratory exacerbations in cystic fibrosis. Thorax 54, 518-523
60. Range, S.P. et al. (1999) Treatment of pulmonary exacerbations of cystic fibrosis leads to improved antioxidant status. Eur. Respir. J. 13, 560-564
61. Lyras, L. et al. (1998) Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies. J. Neurochem. 71, 302-312
62. Floor, E. and Wetzel, M.G. (1998) Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J. Neurochem. 70, 268-275
63. Zusterzeel, P.L. et al. (2001) Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress. Placenta 22, 213-219
64. Dimon-Gadal, S. et al. (2000) Increased oxidative damage to fibroblasts in skin with and without lesions in psoriasis. J. Invest. Dermatol. 114, 984-989
65. Mantle, D. et al. (1999) Quantification of protease activities in synovial fluid from rheumatoid and osteoarthritis cases: comparison with antioxidant and free radical damage markers. Clin. Chim. Acta 284, 45-58
66. Renke, J. et al. (2000) Protein carbonyl groups content as a useful clinical marker of antioxidant barrier impairment in plasma of children with juvenile chronic arthritis. Free Radic. Biol. Med. 29, 101-104
67. Chen, S.S. et al. (2001) Oxidative damage to proteins and decrease of antioxidant capacity in patients with varicocele. Free Radic. Biol. Med. 30, 1328-1334